Bevacizumab in Recurrent Glioma: Patterns of Treatment Failure and Implications

Glioblastoma, the most common primary malignant brain tumor in adults, is highly aggressive and associated with a poor prognosis. Bevacizumab, a monoclonal antibody against the vascular endothelial growth factor receptor, has increasingly been used in the treatment of recurrent glioblastoma. It has...

Full description

Saved in:
Bibliographic Details
Published in:Brain Tumor Res Treat
Main Authors: Li, Yi, Ali, Saad, Clarke, Jennifer, Cha, Soonmee
Format: Artigo
Language:Inglês
Published: The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology 2017
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5433944/
https://ncbi.nlm.nih.gov/pubmed/28516072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14791/btrt.2017.5.1.1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items